• Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Publications
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Conference
    • Newsletter >
      • January 2021
      • April 2021
      • December 2021
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact
EURONEUROTROPHIN
  • Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Publications
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Conference
    • Newsletter >
      • January 2021
      • April 2021
      • December 2021
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact

Early Stage Researchers

14 Early Stage Researchers have been recruited to the EuroNeuroTrophin network to be trained in the discovery of small molecule neurotrophin mimetics as candidate therapeutic agents for neurodegeneration and neuro-inflammation.
Picture
ESR1: Daniele Narducci

​Synthesis of dehydroepiandrosterone (DHEA) derivatives substituted by five or six membered-17-spiro substituents.
Host: National Hellenic Research Foundation, Institute of Chemical Biology

Picture
ESR2: Alessia Latorrata

​Synthesis of dehydroepiandrosterone (DHEA) derivatives substituted by three membered-17-spiro substituents.
Host: National Hellenic Research Foundation, Institute of Chemical Biology

Picture
ESR3: Athanasios-Alexandros Tsengenes

​Computer-aided design and optimization of neurotrophin small molecule mimetics
Host: HITS gGmbH, Molecular and Cellular Modeling Group

Picture
ESR4: Christina Athanasiou

Modelling of mechanistic effects of neurotrophin modulators
Host: HITS gGmbH, Molecular and Cellular Modeling Group

Picture
ESR5: Federica Carucci

X-Ray crystal structure determination of neurotrophin Receptors in complex with small molecules to drive receptor-based drug design.
Host: University of Siena, Department of Biotechnology, Chemistry and Pharmacy

Picture
ESR6: Mirjana Antonijević

In silico screening and Hit to lead development of small molecules neurotrophin receptors ligands.
Host: Université de Caen Normandie, UFR des Sciences Pharmaceutiques, Centre d'Etudes et de Recherche sur le  médicament de Normandie

Picture
ESR7: Paolo Giaccio

Isolation of a new natural neurotrophin mimetics from marine microorganisms.
Host: National and Kapodistrian University of Athens, Faculty of Pharmacy, Department of Pharmacognosy and Chemistry of Natural Products

Picture
ESR8: Canelif Yilmaz

Evaluation of small molecule neurotrophin mimetics in models of neurodegeneration and neuroinflammation
Host: Technische Universität Dresden, Faculty of Medicine, Department of Clinical Pathobiochemistry

Picture
ESR9: Ana Aragón

Development of Human Cell-Based Models for study of Blood Brain Barrier Molecular Permeability
Host: University of Sheffield, Sheffield Institute for Translational Neuroscience (SITraN)

Picture
ESR10: Débora Pita

Cell-Based Models for Neurotrophic Therapeutic Testing
Host: UV University of Amsterdam, Center for Neurogenomics and Cognitive Research

Picture
ESR11: Thanasis Rogdakis

Evaluation of microneurotrophins activity on neurotrophin receptors and their role in signalling, in in vitro and in vivo neurodegenerative conditions, such as Alzheimer’s Disease .
Host: Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology

Picture
ESR12: Despoina Charou

In vitro and in vivo effects of new synthetic and natural compounds on neural stem cells and adult neurogenesis in Alzheimer’s Disease .
Host: Foundation for Research and Technology Hellas, Institute of Molecular Biology and Biotechnology

Picture
ESR13: Evangelia Thanou

Investigation of the potency of small molecule mimetics of neurotrophins to rescue the reduction in synapse number and the aberrant synapse proteome in mouse models of Alzheimer’s Disease .
Host: UV University of Amsterdam, Center for Neurogenomics and Cognitive Research

Picture
ESR14: Marco Destro

Discovery of new neurotrophin mimics using high-through put screening in amyotrophic lateral sclerosis (ALS) patient-derived in vitro models, and taking forward hit compounds into in vivo models.
Host: University of Sheffield, Sheffield Institute for Translational Neuroscience (SITraN)

Picture

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 765704
Disclaimer | Member Area
© accelopment Schweiz 2019. ALL RIGHTS RESERVED.
  • Project
    • Overview
    • Research >
      • Work Packages
      • Individual Research Projects
    • Governance
  • Network
    • Beneficiaries
    • Partner Organisations
  • People
    • Supervisors >
      • Theodora Calogeropoulou
      • Rebecca Wade
      • Stefano Mangani
      • Christophe Rochais
      • Vasileios Roussis
      • Vasileia Ismini Alexaki
      • Achilleas Gravanis
      • Ka Wan Li
      • Dame Pamela Shaw
    • Early Stage Researchers >
      • ESR1: Daniele Narducci
      • ESR2: Alessia Latorrata
      • ESR3: Athanasios-Alexandros Tsengenes
      • ESR4: Christina Athanasiou
      • ESR5: Federica Carucci
      • ESR6: Mirjana Antonijević
      • ESR7: Paolo Giaccio
      • ESR8: Canelif Yilmaz
      • ESR9: Ana Aragón
      • ESR10: Débora Pita
      • ESR11: Thanasis Rogdakis
      • ESR12: Desponia Charou
      • ESR13: Evangelia Thanou
      • ESR14: Marco Destro
    • Scientific Advisory Board
  • Training
    • Approach
    • Objectives >
      • Secondments
    • Events >
      • 1st Network Week
      • 2nd Network Week
      • 3rd Network Week
  • Publications
  • Outreach
    • Events
    • Public Engagement
    • Results
    • Conference
    • Newsletter >
      • January 2021
      • April 2021
      • December 2021
  • News
  • Job Openings
    • Vacancies
    • Submit your application
  • Contact